IRCCS Institute of Neurological Sciences of Bologna- Universita di Bologna

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)	autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, primary dysautonomia, synucleinopathy	Active, not recruiting	Phase 3	2026-07-14		NCT06706622
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease	Muscle Weakness, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease	Recruiting	Phase 2	2026-06-26		NCT05650229

Clinical trials